(Q39835544)

English

Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Allogeneic hematopoietic cell transplantation outcomes for children with B-precursor acute lymphoblastic leukemia and early or late BM relapse (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

1 reference

based on heuristic

inferred from title

lymphoblastic leukemia

1 reference

based on heuristic

inferred from title

author name string

J C Beck

1

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Q Cao

2

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

B Trotz

3

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

A R Smith

4

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

B J Weigel

5

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

M R Verneris

6

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

M J Burke

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

language of work or name

0 references

publication date

20 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

46

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

950-955

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

https://scigraph.springernature.com/pub.10.1038/bmt.2010.217

0 references

Childhood leukemias

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Bone marrow recurrence after initial intensive treatment for childhood acute lymphoblastic leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Childhood acute lymphoblastic leukaemia and relapse

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Hematopoietic cell transplantation for children with acute lymphoblastic leukemia in second complete remission: similar outcomes in recipients of unrelated marrow and umbilical cord blood versus marrow from HLA matched sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Bone marrow transplants from HLA-identical siblings as compared with chemotherapy for children with acute lymphoblastic leukemia in a second remission.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Non-parametric inference for cumulative incidence functions in competing risks studies.

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

A Proportional Hazards Model for the Subdistribution of a Competing Risk

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Mar

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Allogeneic bone marrow transplantation vs chemotherapy for the treatment of childhood acute lymphoblastic leukaemia in second complete remission (revisited 10 years on)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

21 January 2018

Long-term survival of children with leukemia achieved by the end of the second millennium

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow transplantation versus chemotherapy for maintenance of second remission of childhood acute lymphoblastic leukemia: a study of the Children's Cancer Group (CCG-1884)

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation versus chemotherapy for the treatment of childhood acute lymphoblastic leukemia in second remission: a single-institution study

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of childhood acute lymphoblastic leukemia in second remission with allogeneic bone marrow transplantation and chemotherapy: ten-year experience of the Italian Bone Marrow Transplantation Group and the Italian Pediatric Hematology Oncology

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2010.217

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/BMT.2010.217

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39835544&oldid=2091203528"